Experts Recommend Expanding PBS Funding

The Pharmaceutical Benefits Advisory Committee has recommended that the drug triptorelin, already used for prostate cancer, be made available to treat breast cancer, endometriosis, and gender dysphoria. This recommendation could significantly impact healthcare funding policies.